tiprankstipranks
Pharming Group N.V. (PHGUF)
:PHGUF
US Market

Pharming Group (PHGUF) Income Statement

Compare
92 Followers

Pharming Group Income Statement

Last quarter (Q4 2023), Pharming Group's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Pharming Group's net income was $―. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 220.10M$ 188.06M$ 177.73M$ 188.63M$ 147.67M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 3.77M$ -3.02M$ -6.39M$ -6.05M$ 982.00K
EBITDA
$ ―$ 24.22M$ 38.24M$ 50.27M$ 63.77M
Operating Income
$ -24.07M$ 3.76M$ 10.93M$ 74.44M$ 60.91M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -10.55M$ 13.72M$ 15.96M$ 37.73M$ 36.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Pharming Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis